Global technology leader in photonics, Jenoptik, selected Scanfil as a preferred manufacturing partner
Scanfil takes an important step in its growth aspirations in Central Europe as Jenoptik selected Scanfil as a preferred manufacturing partner.
Jenoptik is a German-based global technology leader in photonics and mobility solutions. They selected Scanfil as one of their manufacturing partners in prototyping, PCBAs, box-build, product design, and development.
The collaboration started with prototyping and small series together with the design and development services. Scanfil serves Jenoptik from multiple sites in Europe: Wutha in Germany, Malmö, and Åtvidaberg in Sweden, and Sieradz in Poland.
Scanfil finds its partnership together with Jenoptik extremely interesting and attractive. Jenoptik is a fast-growing global leader in photonics and it has very good growth prospects. Growth in Central Europe is one of Scanfil’s strategic growth targets and new customer acquisition is the key to success.
Director, Investor Relations and External Communications, Scanfil plc
Tel. +358 50 378 2228
Global Sales Manager, Scanfil plc
Tel. +49 172 296 3130
About Scanfil Oyj
Scanfil is an international manufacturing partner and system supplier for the electronics industry with over 45 years of experience in demanding manufacturing. Scanfil provides its customers with an extensive array of services, ranging from product design to product manufacturing, material procurement and logistics solutions. Vertically integrated production and a comprehensive supply chain are the foundation of Scanfil’s competitive advantages: speed, flexibility and reliability. Read more: www.scanfil.com
Jenoptik is a globally operating technology group, optical technologies are the very basis of Jenoptik’s business with the majority of products and services being provided to the photonics market. Company’s key target markets primarily include the semiconductor equipment industry, the medical technology, automotive and mechanical engineering, traffic, aviation as well as the security and defense technology industries. JENOPTIK AG is listed on the German Stock Exchange in Frankfurt and is included in the SDax and TecDax. Read more: www.jenoptik.com
Subscribe to releases from Scanfil Oyj
Subscribe to all the latest releases from Scanfil Oyj by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Scanfil Oyj
Scanfil kutsuu sijoittajat ja talousmedian tehdasvierailulle2.8.2022 11:00:00 EEST | Kutsu
Scanfil kutsuu sijoittajat ja talousmedian tehdasvierailulle Åtvidabergiin, Ruotsiin 7.-8.9.2022. Scanfil Åtvidaberg on sijoittunut lähelle asiakkiden tuotekehitystä, ja se on erikoistunut vaativiin järjestelmäintegraatioihin ja lääketieteen teknologiaan sekä start-up -yritysten tuotteiden teollistamisprosesseihin.
Scanfil invites investors and financial media for a factory visit2.8.2022 11:00:00 EEST | Press Invitation
Scanfil is pleased to invite investors and financial media for a factory visit on the 7th-8th September 2022. Scanfil Åtvidaberg in Sweden is a close-to-customer R&D factory with complex system integration capabilities specializing in medical technology and start-up industrialization processes.
Scanfil will publish its half-year report for January-June 2022 on August 529.7.2022 09:00:00 EEST | Press Invitation
Scanfil plc will publish its half-year report for January-June 2022 on Friday, 5 August 2022, approximately at 8:00 a.m. EET (7:00 a.m. CET).
Scanfil julkistaa tammi-kesäkuun 2022 puolivuosikatsauksensa 5. elokuuta29.7.2022 09:00:00 EEST | Kutsu
Scanfil Oyj julkistaa vuoden 2022 tammi-kesäkuun puolivuosikatsauksensa perjantaina 5.8.2022 noin klo 8:00.
Global ledare inom photonics, Jenoptik, valde Scanfil som strategisk tillverkningspartner8.6.2022 09:00:00 EEST | Tiedote
Scanfil tog ett viktigt steg framåt när det gäller sina tillväxtambitioner i Centraleuropa när Jenoptik valde Scanfil som föredragen tillverkningspartner.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom